[HoKang Biotech] February 2026 Monthly Revenue: NT$0.48 Billion (YoY +20.9%)
HoKang Biotech (1783) announced its February 2026 revenue of NT$0.48 billion, achieving a year-on-year growth of 20.9%. The company, part of the biotechnology and medical industry, specializes in collagen and hyaluronic acid medical materials. This revenue increase reflects strong demand in the medical aesthetics and orthopedics markets.
📋 Article Processing Timeline
- 📰 Published: February 1, 2026 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (1559h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:18 (16h 18m after Collected)
Company Code: 1783
Company Name: HoKang Biotech
Industry: Biotechnology and Medical
Data Month/Year: 2026-02
Current Month Revenue: NT$47,965 Thousand (NT$0.48 Billion)
YoY Change from Previous Year: +20.9%
Company Name: HoKang Biotech
Industry: Biotechnology and Medical
Data Month/Year: 2026-02
Current Month Revenue: NT$47,965 Thousand (NT$0.48 Billion)
YoY Change from Previous Year: +20.9%